Experimental pancreatic cancer vaccine shows positive trial results

A clinical trial of an experimental 'ready-to-use' vaccine for pancreatic cancer has yielded positive results, according to researchers. The vaccine's efficacy and safety profile remain partially disclosed, and larger trials are needed to confirm durability. This marks a potential advance in a cancer type with historically poor outcomes.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works